Skip to content
Research Article Open access CC BY 4.0

Anti-retroviral Treatment Related Haematological Disorders among HIV- Infected Children Attending HIV Clinic at Yekatit 12 Hospital, Addis Ababa, Ethiopia

Mestewat Debasu, M. K. C. Menon, Yididya Belayneh, Workeabeba Abebe, Degu Jerene, Daniel Seifu

International Blood Research & Reviews · pp. 1–18 · Published 5 Sep 2015

10.9734/IBRR/2015/20197

Abstract

Background: The Management of drug toxicities is increasingly becoming a crucial component of human immunodeficiency virus infection and improvement of antiretroviral therapy in developing countries like Ethiopia. The severity of hematological abnormalities in children who are taking ART is not known well in Ethiopian Hospitals. Objective: The study was undertaken to determine the severity of HAART related hematological disorders in HIV positive children who were on HAART at Yekatit 12 Hospital, Addis Ababa, Ethiopia. Methods: A cross sectional study was conducted from May 2012 to February 2013 among children who had been on HAART for maximum of twelve months. Data collection using questionnaires and measurement of complete blood count and CD4 + T cell counts were made by using standard methodology. The results were tested using appropriate statistical methods (mean, Standard Deviation, Odd Ratio, p-value and F test value). Results: A total of 106 patients (<18 years) were enrolled  in the study and had a mean age of 6.5±3.4 years, a median age of 7 years and female to male ratio of 1.04:1. The prevalence of anemia was 18.9%, 12.3% and 10.4% at baseline, at six months, and at twelve months post-treatment, respectively. Their mean hemoglobin level increased by 1.0 gm/dl at six months and by 1.7 gm/dl at twelve months of follow up with statistically significant values (p <0.001), and F test value presented 15.87. Patients who were put on AZT based regimen were more likely to develop anemia than those on D4T-based regimen, (OR=4.5, p-value <0.05). The prevalence of thrombocytopenia at baseline was 8.5%, but it was lowered for both at six and twelve months by 5.7%. The thrombocyte count of AZT based regimen showed statistically significant association (p- <0.05) and F test value as 2.98. The prevalence of neutropenia at baseline and at six months was similar with the value of 2.8% while at twelve months it was higher at 5.7%. Conclusion: Anemia, neutropenia and thrombocytopenia were the hematological abnormalities among HIV infected Ethiopian children taking HAART. Anemia was the most common abnormality, but significantly lesser than in many other hospitals in Ethiopia and among those who were on AZT based regimen. It is recommended that even in limited laboratory monitoring, HAART can be safely used and health professionals may consider other risk factors associated with the development of cytopenia before selection of second line of HAART drug regimen.  

HAART anemia neutropenia thrombocytopenia Ethiopian children

References (25)

  1. 1 HIV evolution: CTL escape mutation and reversion after transmission [DOI]
  2. 2 Epidemiology of Anemia in Human Immunodeficiency Virus (HIV)-Infected Persons: Results From the Multistate Adult and Adolescent Spectrum of HIV Disease Surveillance Project [DOI]
  3. 3 Prevalence and outcomes of anemia in individuals with human immunodeficiency virus: a systematic review of the literature [DOI]
  4. 4 HIV-ASSOCIATED VENOUS THROMBOEMBOLISM [DOI]
  5. 5 HIV-associated anemia in children: a systematic review from a global perspective [DOI]
  6. 6 Anaemia in persons with HIV infection: prognostic marker and contributor to morbidity.
  7. 7 4th International AIDS Society Conference on HIV Pathogenesis, Treatment and Prevention [DOI]
  8. 8 Anemia and Risk Factors in HAART Naïve and HAART Experienced HIV Positive Persons in South West Ethiopia: A Comparative Study [DOI]
  9. 9 Haematological complications of HIV Infection [DOI]
  10. 10 Prevalence of anaemia among HIV-infected patients in Benin City, Nigeria [DOI]
  11. 11 Hematological manifestations of human immunodeficiency virus infection and the effect of highly active anti-retroviral therapy on cytopenia [DOI]
  12. 12 Folate, vitamin B12, and HIV infection [DOI]
  13. 13 Low serum vitamin B12 levels in an outpatient HIV-infected population [DOI]
  14. 14 Symptomatology of anemia [DOI]
  15. 15 Hematologic Abnormalities in Treatment-naïve HIV Patients [DOI]
  16. 16 Magnitude of Anemia and Associated Factors among Pediatric HIV/AIDS Patients Attending Zewditu Memorial Hospital ART Clinic, Addis Ababa, Ethiopia [DOI]
  17. 17 Zidovudine-induced reversible pure red cell aplasia [DOI]
  18. 18 Prevalence of antibodies to haart agents among hiv patients in benin city, nigeria [DOI]
  19. 19 Safety of antiretroviral drug therapy in Jamaican children with HIV/AIDS.
  20. 20 Cobalamin deficiency in patients infected with the human immunodeficiency virus.
  21. 21 Adverse Events in HIV- infected Children on Antiretroviral Therapy at a Teaching Hospital in Lagos, Nigeria: A Retrospective Study [DOI]
  22. 22 A Review of Pediatric Human Immunodeficiency Virus Infection [DOI]
  23. 23 Pre-ART retention in care and prevalence of tuberculosis among HIV-infected children at a district hospital in southern Ethiopia [DOI]
  24. 24 Immunological response among HIV/AIDS pat ients before and after ART therapy at Zewuditu Hospital Addis Ababa, Ethiopia
  25. 25 Impact of Art Mother and Child on The HIV Status of the Child Born to HIVPositive Mothers in Burkina Faso: Towards the Adoption of an Effective Pmtct Policy [DOI]

Cited by 8

Predictors of anemia among HIV-infected children in Ethiopia: systematic review and meta-analysis

Desalegn Girma, Zinie Abita, Wubetu Agegnehu · Scientific Reports · 2025

Immuno-hematological parameters among adult HIV patients before and after initiation of Dolutegravir based antiretroviral therapy, Addis Ababa, Ethiopia

Ayantu Gudina, Moges Wordofa, Fekadu Urgessa · PLoS ONE · 2024

A systematic review and meta-analysis of the prevalence and predictors of anemia among children in Ethiopia

Alemu Gebrie, Animut Alebel · African Health Sciences · 2020

Magnitude of anemia and undernutrition among HIV-infected children who took HAART: a retrospective follow-up study.

M. Melku, Bamlaku Enawgaw, Sisay Ayana · American Journal of Blood Research · 2020

Hematological and immunological abnormalities among children receiving highly active antiretroviral therapy at Hawassa University College of Medicine and Health Sciences, Southern Ethiopia

Demissie Assegu Fenta, Temesgen Bizuayehu Wube, Metsihet Mohammed Nuru · 2020

Burden of anemia and its association with HAART in HIV infected children in Ethiopia: a systematic review and meta-analysis

Fasil Wagnew, Setegn Eshetie, Animut Alebel · BMC Infectious Diseases · 2019

Magnitude and Factors Associated with Cytopenia Among Children on Highly Active Antiretroviral Therapy at Hawassa University College of Medicine and Health Science, Sidama Region, Southern Ethiopia

Metsihet Mohammed Nuru, Temesgen Bizuayehu Wube, Demissie Assegu Fenta · HIV/AIDS - Research and Palliative Care · 2023

Hematological parameters abnormalities and associated factors in HIV-positive adults before and after highly active antiretroviral treatment in Goba Referral Hospital, southeast Ethiopia: A cross-sectional study

Negesso Duguma, Girum Tesfaye Kiya, Wondimagegn Adissu Maleko · SAGE Open Medicine · 2021

Related research

Article metrics

Real usage data collected on this platform.

45

Page views

0

PDF downloads

12

Outbound clicks

8

Citations

Views over time

Views by country

Approximate, from request IP at view time — not citizenship or institution. Countries with fewer than 5 views are grouped as "Other".

Traffic sources

Referring site, by host.

Views and downloads exclude known bots/crawlers. Citations combines this platform's own DOI-resolved index with each external source's own reported total — see Cited by above for individually listed citing works. Last refreshed 0 seconds ago.